The Regulatory Situation After the Trump Executive Orders Regulatory Freeze Pending Review
Additional Compensation from the Government: A Brief Comparison of REAs and Claims
DE Under 3: EEOC Quietly Denys FOIA Requests, Pay Data Study Results & OFCCP Clears Up AAP Portal “Deadline” Confusion
DE Under 3: Secretary Walsh Intervenes in Court, Religious Exemption Updates, & AAP Verification Deadline Extension Developments
DE Under 3: USDOJ’s Settlement Affecting Recruiters, OFCCP’s AAP Verification Deadline Extension & SCOTUS’ New Ruling
PODCAST: Williams Mullen's Benefits Companion - Health Plan Transparency Requirements
The Critical Nature of Bankruptcy Dates and Deadlines
Government Contractors: Preparing for OFCCP’s Affirmative Action Program Compliance Certification
COBRA Deadlines and Proofs of Mailing in Carter v. Southwest Airlines Co. Board of Trustees
#WorkforceWednesday: DOL Electronic Notices Guidance, EEO-1 Reporting Delayed, CA COVID-19 Paid Sick Leave - Employment Law This Week®
Information Blocking: How Will the New Rule Impact the Health Care Industry?
COVID-19 Impact for Health & Welfare Plans (Troutman Sanders and Pepper Hamilton COVID-19 Issues for Employers Podcast Series)
Underwriters, Universities and Government Debt Issuers Face a Critical Deadline
Obamacare Provision Requiring Businesses to Provide Health Insurance Delayed Until 2015
Former SEC Chairman David Ruder Discusses the Dodd-Frank Timeline, Volcker Rule & Cost Benefit Rules (Part 2 of 2)
Glucagon-like peptide-1 agonists, a class of medications known as GLP-1s, have grown in popularity, initially for the treatment of type 2 diabetes and more recently for obesity and other labeled and off-label indications for...more
On December 10, the Centers for Medicare & Medicaid Services (CMS) published a proposed rule, which, if finalized as proposed, has potentially significant implications for Medicare Advantage (MA) plans and Medicare...more
On June 22, 2023, DEA published a final rule regarding the timing with which registrants are required to report the theft or loss of controlled substances (the “Final Rule”). 88 FR 40707. DEA’s regulations have always...more
The House and Senate were both in session this week. The House Ways & Means Health Subcommittee met to discuss policies inhibiting innovation and patient access, and the House Energy & Commerce Health Subcommittee held a...more